Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)

Palestine flag Palestine · Delayed Price · Currency is JOD · Price in USD
4.850
+0.050 (1.04%)
At close: Mar 25, 2026
Market Cap61.89M +42.6%
Revenue (ttm)35.40M +25.4%
Net Income7.25M +103.1%
EPS0.40 +102.9%
Shares Out18.00M
PE Ratio8.54
Forward PEn/a
Dividend0.06 (1.65%)
Ex-Dividend DateApr 16, 2026
Volume360
Average Volume2,030
Open4.590
Previous Close4.800
Day's Range4.590 - 4.850
52-Week Range3.550 - 4.930
Beta-0.00
RSI64.14
Earnings DateMar 10, 2026

About Jerusalem Pharmaceuticals

Jerusalem Pharmaceuticals Co. Ltd., together with its subsidiaries, develops, manufactures, and markets pharmaceutical products in Palestine, the Middle East, North Africa, and internationally. The company offers over the counter, prescription pharmaceutical, and nutritional supplements products in various dosage forms, including tablets, capsules, sterile injectables, powders for suspensions, suspensions, syrups, powders, suppositories, ovules, creams, and ointments, as well as ear and nose drops and solutions. It also provides medical devices... [Read more]

Industry Pharmaceutical Preparations
Founded 1969
Employees 531
Stock Exchange Palestine Stock Exchange
Ticker Symbol JPH
Full Company Profile

Financial Performance

In 2025, Jerusalem Pharmaceuticals's revenue was $49.93 million, an increase of 25.39% compared to the previous year's $39.82 million. Earnings were $10.23 million, an increase of 103.10%.

Financial numbers in USD Financial Statements